Article
Remimazolam Suppresses Oxidative Stress and Apoptosis in Cerebral Ischemia/Reperfusion…
Drug Design, Development and Therapy · 2025 · Duan M, Yu N, Liu J, Zhao Y, Zhang J, Song S, Wang S
Key facts
| Title | Remimazolam Suppresses Oxidative Stress and Apoptosis in Cerebral Ischemia/Reperfusion Injury by Regulating AKT/GSK-3β/NRF2 Pathway |
|---|---|
| First author | Duan M, Yu N, Liu J, Zhao Y, Zhang J, Song S, Wang S |
| Journal | Drug Design, Development and Therapy |
| Published | Jan 8, 2025 |
| DOI | 10.2147/DDDT.S478692 |
| Devices mentioned | 210294 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1